ADACEL POLIO
INJ SUS ISP 1X0,5ML+1PJ
| SÚKL code | 0244245 |
|---|---|
| Name of the product | ADACEL POLIO |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | ADACEL POLIO |
| Supplement | INJ SUS ISP 1X0,5ML+1PJ |
| Strenght | |
| Pharmaceutical form | Suspension for injection in pre-filled syringe |
| Package | 1X0,5ML+1PJ |
| Route | Intramuscular use |
| Language of the pack | Czech |
| Wrap type | Pre-filled syringe |
| Legal status | na lékařský předpis |
| Active substance |
DIPHTHERIA TOXOID (DIPHTHERIAE ANATOXINUM) TETANUS TOXOID (TETANI ANATOXINUM) POLIOMYELITIS VIRUS TYPE 1, INACTIVATED (VIRUS POLIOMYELITIDIS TYPUS 1 INACTIVATUM) POLIOMYELITIS VIRUS TYPE 2, INACTIVATED (VIRUS POLIOMYELITIDIS TYPUS 2 INACTIVATUM) POLIOMYELITIS VIRUS TYPE 3, INACTIVATED (VIRUS POLIOMYELITIDIS TYPUS 3 INACTIVATUM) PERTUSSIS TOXOID (PERTUSSIS ANATOXINUM) PERTUSSIS FILAMENTOUS HAEMAGGLUTININ (PERTUSSIS HAEMAGGLUTININUM FILAMENTOSUM) PERTACTIN (PERTACTINUM) FIMBRIAE TYPE 2 AND 3 (FIMBRIAE TYPI 2 ET 3) |
| ATC group | J07CA02 |
| ATC group name | DIFTERIE-PERTUSE-POLIOMYELITIDA-TETANUS |
Marketing authorisation information
| Registration Number | 59/ 265/19-C |
|---|---|
| Type of MA | A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state |
| MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
| Placed on the market till | 30. 09. 2021 |
| MA Holder | Sanofi Pasteur, Lyon |
| MA Holder country | FRANCIE |
| Actual MA holder | Sanofi Pasteur, Lyon |
| Actual MA holder country | FRANCIE |
cz